Arcus Biosciences (RCUS) Treasury Shares (2016 - 2025)

Arcus Biosciences has reported Treasury Shares for 10 years, with the latest figure at $2.9 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 31.82% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.9 million (up 31.82% YoY), and the FY2025 full-year result was $2.9 million, up 31.82% from the prior year.
• Treasury Shares for Q4 2025 stood at $2.9 million, up from $2.2 million in the prior quarter.
• The five-year high for Treasury Shares was $2.9 million in Q4 2025, with the low at $1.1 million in Q4 2021.
• Average Treasury Shares over 5 years is $1.8 million, with a median of $1.5 million recorded in 2023.
• Year-over-year, Treasury Shares surged 48.92% in 2021 and grew 15.38% in 2023.
• Tracing RCUS's Treasury Shares over 5 years: stood at $1.1 million in 2021, then rose by 18.18% to $1.3 million in 2022, then advanced by 15.38% to $1.5 million in 2023, then soared by 46.67% to $2.2 million in 2024, then surged by 31.82% to $2.9 million in 2025.
• The last three Treasury Shares figures came in at $2.9 million (Q4 2025), $2.2 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.

Peer Comparison